CVE-2026-21970
Essential information
- Published
- 20/01/2026 22:16
- Modified
- 20/01/2026 22:16
- Author
- —
- Creator
- —
- CVSS
- 6.5 MEDIUM (v3.1)
- CISA KEV
- No
- CWE
- —
- CVSS vector
-
—
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N—
CVSS metrics
- Access vector
- —
- Access complexity
- —
- Authentication
- —
- Confidentiality impact
- —
- Integrity impact
- —
- Availability impact
- —
- Exploitability
- —
- Remediation level
- —
- Report confidence
- —
- Temporal score
- —
- Attack vector
- NETWORK
- Attack complexity
- LOW
- Privileges required
- LOW
- User interaction
- NONE
- Scope
- UNCHANGED
- Confidentiality impact
- HIGH
- Integrity impact
- NONE
- Availability impact
- NONE
- Exploit code maturity
- —
- Remediation level
- —
- Report confidence
- —
- Temporal score
- —
- Attack vector
- —
- Attack complexity
- —
- Attack requirements
- —
- Privileges required
- —
- User interaction
- —
- Confidentiality (V)
- —
- Confidentiality (S)
- —
- Integrity (V)
- —
- Integrity (S)
- —
- Availability (V)
- —
- Availability (S)
- —
- Exploit maturity
- —
Description
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
NVD status
- Status
- Received — CVE has been recently published to the CVE List and has been received by the NVD.
- Source
- [email protected]
- NVD
- View on NVD
Affected products (CPE)
| Product | CPE |
|---|---|
| oracle / life sciences central designer | cpe:2.3:a:oracle:life_sciences_central_designer:7.0.1.0:*:*:*:*:*:*:* |